Susan Ragland Baucom

About Susan Ragland Baucom

Leader | Motivator | Collaborator | Strategic Planner | Critical Thinker | Problem SolverEnthusiastic global Project Leader with 25+ year track record of successfully delivering clinical trials projects, including mega-projects, primarily in the cardiovascular, diabetes, and obesity therapeutic areas: • Builds strong relationships and collaborates across functions and organizations to solve problems• Creates high performing teams through engagement, talent development and leading with passion• Shifts quickly from big picture oversight to deep dive analyses to drive goals• Focuses on innovation, efficiency, creative solutions, and actions• Exposes and mitigates risks proactively and manages issues to closure• High \"I\" influencer on DiSC profile and ESTJ on Myers Briggs.CLINICAL TRIAL EXPERIENCE• Sponsors: Small biotech to large pharma customers• Projects involving Academic Research Organizations (AROs): e.g, C5Research, DCRI, TIMI• Projects involving partnership with multiple Contract Research Organizations (CROs): e.g, IQVIA, Covance, Julius Clinical• Study design: Traditional (onsite subject visits) and virtual hybrid (home visits, telemedicine, e-consent)• Therapeutic areas: Overweight/Obesity with and without co-morbidities such as T2DM; Diabetes (T1DM and T2DM), COPD/Asthma, Hyperlipidemia, HF, UA/NSTEMI ACS, IBS-d and IBS-c, Overactive Bladder, and Osteoporosis• Study medication delivery: oral, injection, inhaled (insulin), infusion and surgically implanted devices• Monitoring models: Traditional 100% SDV to Risk Based Monitoring (RBM)• Single protocol to clinical programs with multiple protocols• Drug development stages: Phase II – IV, including CVOTs• Project services: Project Management, Feasibility, Site Identification, Regulatory, Site Start-Up, Clinical Trial Educators, Medical Services, Investigator Meeting Planning, Clinical Monitoring, Patient Recruitment and Retention, Data Management, Clinical Endpoint Validation Adjudication (CEVA), Biostatistics, Medical Writing, Quality Assurance, Records Information, Pharmacovigilance (Safety), Investigator Payments, Investigator Portal (Health Engagement Communication), Central Laboratory, IXRS • Project phases: Bid defense, start-up, maintenance (interim data locks), to study closure (e.g, final TMF and TLF/CSR delivery) • Domestic to Global: Single country to 55 countries• Number of clinical research sites: 30 to 1,400 sites (private clinics to in-hospital settings)• Number of randomized subjects: 100 to >15k randomized subjectsPMI PMP certification in 2009.

Experience

1. Senior Clinical Project Management Director

   IQVIA

   Jul 2021 — Present

Education

• University of Wisconsin-Platteville

  Master of Science - MS, Project Management

  2023

• North Carolina State University

  B.S., Biology, Business Managment

  1990 — 1994